These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 24697521)

  • 1. Fibroblast growth factor 21: a promising therapeutic target in obesity-related diseases.
    Cheung BM; Deng HB
    Expert Rev Cardiovasc Ther; 2014 Jun; 12(6):659-66. PubMed ID: 24697521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.
    Woo YC; Xu A; Wang Y; Lam KS
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):489-96. PubMed ID: 23134073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-α represses β-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway.
    Díaz-Delfín J; Hondares E; Iglesias R; Giralt M; Caelles C; Villarroya F
    Endocrinology; 2012 Sep; 153(9):4238-45. PubMed ID: 22778214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating fibroblast growth factor 21 is induced by peroxisome proliferator-activated receptor agonists but not ketosis in man.
    Christodoulides C; Dyson P; Sprecher D; Tsintzas K; Karpe F
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3594-601. PubMed ID: 19531592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of β-Klotho in Adipose Tissue Sensitizes Male Mice to Endogenous FGF21 and Provides Protection From Diet-Induced Obesity.
    Samms RJ; Cheng CC; Kharitonenkov A; Gimeno RE; Adams AC
    Endocrinology; 2016 Apr; 157(4):1467-80. PubMed ID: 26901091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
    Iglesias P; Selgas R; Romero S; Díez JJ
    Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Potential Role of Fibroblast Growth Factor 21 in Lipid Metabolism and Hypertension.
    Huang Z; Xu A; Cheung BMY
    Curr Hypertens Rep; 2017 Apr; 19(4):28. PubMed ID: 28337713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugated linoleic acid induces hepatic expression of fibroblast growth factor 21 through PPAR-α.
    Yu J; Yu B; Jiang H; Chen D
    Br J Nutr; 2012 Feb; 107(4):461-5. PubMed ID: 21767451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutritional regulation of fibroblast growth factor 21: from macronutrients to bioactive dietary compounds.
    Pérez-Martí A; Sandoval V; Marrero PF; Haro D; Relat J
    Horm Mol Biol Clin Investig; 2016 Sep; 30(1):. PubMed ID: 27583468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors.
    Chow WS; Xu A; Woo YC; Tso AW; Cheung SC; Fong CH; Tse HF; Chau MT; Cheung BM; Lam KS
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2454-9. PubMed ID: 23887638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma FGF21 concentrations, adipose fibroblast growth factor receptor-1 and β-klotho expression decrease with fasting in northern elephant seals.
    Suzuki M; Lee AY; Vázquez-Medina JP; Viscarra JA; Crocker DE; Ortiz RM
    Gen Comp Endocrinol; 2015 May; 216():86-9. PubMed ID: 25857751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARalpha is a key regulator of hepatic FGF21.
    Lundåsen T; Hunt MC; Nilsson LM; Sanyal S; Angelin B; Alexson SE; Rudling M
    Biochem Biophys Res Commun; 2007 Aug; 360(2):437-40. PubMed ID: 17601491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21.
    Inagaki T; Dutchak P; Zhao G; Ding X; Gautron L; Parameswara V; Li Y; Goetz R; Mohammadi M; Esser V; Elmquist JK; Gerard RD; Burgess SC; Hammer RE; Mangelsdorf DJ; Kliewer SA
    Cell Metab; 2007 Jun; 5(6):415-25. PubMed ID: 17550777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice.
    Lin Z; Pan X; Wu F; Ye D; Zhang Y; Wang Y; Jin L; Lian Q; Huang Y; Ding H; Triggle C; Wang K; Li X; Xu A
    Circulation; 2015 May; 131(21):1861-71. PubMed ID: 25794851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic actions of fibroblast growth factor 21.
    Cuevas-Ramos D; Aguilar-Salinas CA; Gómez-Pérez FJ
    Curr Opin Pediatr; 2012 Aug; 24(4):523-9. PubMed ID: 22732636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of energy metabolism by long-chain fatty acids.
    Nakamura MT; Yudell BE; Loor JJ
    Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice.
    Lin Z; Tian H; Lam KS; Lin S; Hoo RC; Konishi M; Itoh N; Wang Y; Bornstein SR; Xu A; Li X
    Cell Metab; 2013 May; 17(5):779-89. PubMed ID: 23663741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride.
    Li H; Fang Q; Gao F; Fan J; Zhou J; Wang X; Zhang H; Pan X; Bao Y; Xiang K; Xu A; Jia W
    J Hepatol; 2010 Nov; 53(5):934-40. PubMed ID: 20675007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF21 resistance is not mediated by downregulation of beta-klotho expression in white adipose tissue.
    Markan KR; Naber MC; Small SM; Peltekian L; Kessler RL; Potthoff MJ
    Mol Metab; 2017 Jun; 6(6):602-610. PubMed ID: 28580290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oxidized low density lipoprotein and peroxisome proliferator-activated receptor α induced endogenous fibroblast growth factor 21 upregulation is protective against apoptosis in cardiac endothelial cells].
    Liu JH; Lü Y; Zhang LK; DU J; Zeng XJ; Hao G; Zhao DH; Wang GZ; Zhang YC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Dec; 38(12):1113-7. PubMed ID: 21215149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.